结论：卡培他滨和奥沙利铂用于先前未经治疗的食管癌和胃癌患者，效果分别与氟尿嘧啶和顺铂相同。

Conclusions Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer.

youdao

先前未经治疗、而对利妥昔单抗诱导缓解有效后接受延长治疗的患者中，8年有45%患者仍无事件发生。

Of previously untreated patients receiving prolonged treatment after responding to rituximab induction, at 8 years 45% were still without event.

youdao

先前未经治疗、而对利妥昔单抗诱导缓解有效后接受延长治疗的患者中，8年有45%患者仍无事件发生。

Of previously untreated patients receiving prolonged treatment after responding to rituximab induction, at 8 years 45% were still without event.

youdao